|
| 產(chǎn)地 | 進口、國產(chǎn) |
| 品牌 | 上海莼試 |
| 保存條件 | Store at -20 °C |
| 貨號 | CS10077 |
| 應用范圍 | WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200 |
| CAS編號 | |
| 抗體名 | Anti-OGT/O-GlcNAc transferase |
| 克隆性 | |
| 靶點 | 詳見說明書 |
| 適應物種 | 詳見說明書 |
| 形態(tài) | 詳見說明書 |
| 宿主 | 詳見說明書 |
| 亞型 | IgG |
| 標識物 | 詳見說明書 |
| 濃度 | 1mg/1ml% |
| 免疫原 | KLH conjugated synthetic peptide derived from human O-GlcNAc transferase |
O位N-乙酰葡萄糖胺OGT抗體費用 英文名稱 Anti-OGT/O-GlcNAc transferase
中文名稱 O位N-乙酰葡萄糖胺OGT抗體費用
別 名 HRNT1; MGC22921; O-GlcNAc transferase; O GlcNAc; O-Linked N-Acetylglucosamine Transferase; O GlcNAc transferase p110 subunit; O GlcNAc transferase subunit p110; O linked N acetylglucosamine (GlcNAc) transferase (UDP N acetylglucosamine:polypeptide N acetylglucosaminyl transferase); O linked N acetylglucosamine transferase 110 kDa subunit; O-GlcNAc transferase subunit p110; O-linked N-acetylglucosamine transferase 110 kDa subunit; OGT; OGT1_HUMAN; UDP N acetylglucosamine peptide N acetylglucosaminyltransferase 110 kDa subunit; UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit; Uridinediphospho N acetylglucosamine:polypeptide beta N acetylglucosaminyl transferase.
產(chǎn)品屬性：
濃 度 1mg/1ml
規(guī) 格 0.2ml/200μg
抗體來源 Rabbit
克隆類型 polyclonal
交叉反應 Human, Mouse, Rat, Cow
產(chǎn)品類型 一抗
研究領(lǐng)域 神經(jīng)生物學 信號轉(zhuǎn)導 轉(zhuǎn)錄調(diào)節(jié)因子 Alzheimer's
蛋白分子量 predicted molecular weight: 117kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human O-GlcNAc transferase
亞 型 IgG
純化方法 affinity purified by Protein A
儲 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
O位N-乙酰葡萄糖胺OGT抗體費用 產(chǎn)品應用 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200
（石蠟切片需做抗原修復）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 Addition of nucleotide-activated sugars directly onto the polypeptide through O-glycosidic linkage with the hydroxyl of serine or threonine. Mediates the O-glycosylation of MLL5 and HCFC1. Promotes proteolytic maturation of HCFC1. Since both phosphorylation and glycosylation compete for similar serine or threonine residues, the two processes may compete for sites, or they may alter the substrate specificity of nearby sites by steric or electrostatic effects. O-GlcNAc transferase has been purified from rat liver. It exists as a heterotrimeric complex with two subunits of the same molecular mass and one shorter subunit. Both polypeptides are related; the short subunit band is either a proteolytic product of the polypeptide or the product of an alternative translation start site. O-GlcNAc transferase is expressed as multiple transcripts that are present in different amounts in various human tissues, with the highest levels of expression in pancreas. Immunofluorescence of human cells expressing rat O-GlcNAc transferase indicated that it is present in both the nucleus and cytosol. HeLa cells expressing O-GlcNAc transferase do not survive well during prolonged incubations, suggesting that this protein may be toxic to the cells.
Function : Catalyzes the transfer of a single N-acetylglucosamine from UDP-GlcNAc to a serine or threonine residue in cytoplasmic and nuclear proteins resulting in their modification with a beta-linked N-acetylglucosamine (O-GlcNAc). Glycosylates a large and diverse number of proteins including histone H2B, AKT1, MLL5, MAPT/TAU and HCFC1. Can regulate their cellular processes via cross-talk between glycosylation and phosphorylation or by affecting proteolytic processing. Involved in insulin resistance in muscle and adipocyte cells via glycosylating insulin signaling components and inhibiting the 'Thr-308' phosphorylation of AKT1, enhancing IRS1 phosphorylation and attenuating insulin signaling. Component of a THAP1/THAP3-HCFC1-OGT complex that is required for the regulation of the transcriptional activity of RRM1. As part of the NSL complex it may be involved in acetylation of nucleosomal histone H4 on several lysine residues.
Isoform 2, the mitochondrial isoform (mOGT), is cytotoxic and triggers apoptosis in several cell types including INS1, an insulinoma cell line.
Subunit : Heterotrimer; consists of one 78 kDa subunit and two 110 kDa subunits dimerized via TPR repeats 6 and 7. Interacts (via TPR repeats 6 and 7) with ATXN10 (By similarity). Component of the MLL5-L complex, at least composed of MLL5, STK38, PPP1CA, PPP1CB, HCFC1, PPP1CC and ACTB. Component of a THAP1/THAP3-HCFC1-OGT complex. Component of the NSL complex at least composed of MOF/KAT8, KANSL1, KANSL2, KANSL3, MCRS1, PHF20, OGT1/OGT, WDR5 and HCFC1. Interacts directly with HCFC1; the interaction O-glycosylates HCFC1, regulates its proteolytic processing and transcriptional activity and, in turn, stabilizes OGT in the nucleus. Interacts (via TPRs 1-6) with SIN3A; the interaction mediates transcriptional repression in parallel with histone deacetylase.
Subcellular Location : Isoform 2: Mitochondrion. Membrane. Note=Associates with the mitochondrial inner membrane. Isoform 3: Cytoplasm. Nucleus. Cell membrane. Note=Mostly in the nucleus. Retained in the nucleus via interaction with HCFC1. After insulin induction, translocated from the nucleus to the cell membrane via phophatidylinisotide binding. Colocalizes with AKT1 at the plasma membrane. Isoform 4: Cytoplasm. Nucleus.
Tissue Specificity : Highly expressed in pancreas and to a lesser extent in skeletal muscle, heart, brain and placenta. Present in trace amounts in lung and liver.
Post-translational modifications : Ubiquitinated, leading to its proteasomal degradation.
DISEASE : Note=Regulation of OGT activity and altered O-GlcNAcylations are implicated in diabetes and Alzheimer disease. O-GlcNAcylation of AKT1 affects insulin signaling and, possibly diabetes. Reduced O-GlcNAcylations and resulting increased phosphorylations of MAPT/TAU are observed in Alzheimer disease (AD) brain cerebrum.
Similarity : Belongs to the O-GlcNAc transferase family.
Contains 13 TPR repeats.
實驗流程：
全、新、優(yōu)、品、好四大特點：
O位N-乙酰葡萄糖胺OGT抗體費用 全：公司提供上萬種產(chǎn)品，涵蓋了生物試劑，elisa試劑盒，標準品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細胞等，基本上各種科研所需產(chǎn)品在我司都能找到。
新：產(chǎn)品更新速度較快，基本上每周都有新產(chǎn)品出現(xiàn)。
優(yōu)：產(chǎn)品質(zhì)量好，投訴比較少。
好：我公司具有優(yōu)質(zhì)的技術(shù)團隊，產(chǎn)品一旦售出，實驗過程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時沒有任何的后顧之憂。
正在熱銷的相關(guān)產(chǎn)品：
Anti-Caspase-6 (CT)/FITC 熒光素標記半胱胺酸蛋白酶蛋白-6抗體(C端)IgGMulti-class antibodies規(guī)格： 0.2ml
Anti-HA tag/FITC 熒光素標記HA tag標簽抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh CGA/ Chromogranin A 嗜鉻粒素A抗體 規(guī)格 0.1ml
TRAF3/CD40bp (CD40 binding protein) 壞死因子受體相關(guān)蛋白3抗原 0.5mg
IL-6 英文名稱： 白介素6 0.1ml
Rhesus antibody Rh TLS/FUS 粘液樣脂肪蛋白FUS1抗體 規(guī)格 0.2ml
Anti-HA tag/FITC 熒光素標記HA tag標簽抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Human visfatin 人內(nèi)臟脂肪素Multi-class antibodies規(guī)格： 48T
Anti-CIDEB 促進凋亡基因抗體Multi-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh NUBP1 核苷酸結(jié)合蛋白1抗體 規(guī)格 0.2ml
RNAin RNAin(非凍型RNA樣品保存液) 10ml
TOP1MT 英文名稱： 線粒體DNA拓普西異構(gòu)酶Ⅰ抗體 0.1ml
phospho-CDKN1B (Ser10) 英文名稱： 磷酸化P27抗體/周期素依賴激酶抑制劑 0.1ml
Anti-CIDEB 促進凋亡基因抗體Multi-class antibodies規(guī)格： 0.2ml
pre-X protein[Hepatitis B virus]N-Terminus 乙毒pre-X蛋白抗原(N端)Multi-class antibodies規(guī)格： 0.5mg
Anti-Aurora A/B/C 有絲分裂激酶A/B/C抗體Multi-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh phospho-Akt(Thr308) 磷酸化蛋白激酶B抗體 規(guī)格 0.1ml
MBP 濃縮液 0.1ml 進口分裝
UNC93B 英文名稱： 內(nèi)質(zhì)網(wǎng)膜蛋白UNC93B抗體 0.2ml
Choline kinase alpha 英文名稱： 乙醇胺激酶α抗體 0.1ml
Anti-Aurora A/B/C 有絲分裂激酶A/B/C抗體Multi-class antibodies規(guī)格： 0.2ml
SHH Protein Mouse 重組小鼠 SHH / Sonic hedgehog 蛋白 (His 標簽)
KP-N-NS 人腎上腺神經(jīng)母細胞瘤()
TNFRSF9 Others Mouse 小鼠 4-1BB / TNFRSF9 / CD137 人細胞裂解液 (陽性對照)
SiHa人子宮頸鱗癌細胞 SiHa human uterine cervical squamous cell carcinoma MEM培養(yǎng)基(GIBCO)+10%FBS
人APP-PS1雙基因轉(zhuǎn)染CHO細胞株;7WPS1
小鼠星形膠質(zhì)細胞(MA)(5×105) CaEs-17, 人細胞株 Human
CL-0334EB-3(人Butt細胞)5×106cells/瓶×2
IL1R2 Others Human 人 IL1R2 / IL1RB / CD121b 人細胞裂解液 (陽性對照)
人口腔角質(zhì)細胞總RNAHOK NA
MDA-MB-415細胞，人癌細胞 鼠胚成纖維細胞系,STO細胞 原代成纖維細胞特制基礎(chǔ)無血清培養(yǎng)基Many types of cells包裝：500/100ml
PA319(人細胞) 5×106cells/瓶×2
HDLEC Pellet 人類皮膚淋巴管內(nèi)皮細胞團塊(少年者) > 1 mio.cells 少突膠質(zhì)前體細胞生長添加物OPCGS
O位N-乙酰葡萄糖胺OGT抗體費用 SHH Protein Mouse 重組小鼠 SHH / Sonic hedgehog 蛋白 (His 標簽)
KP-N-NS 人腎上腺神經(jīng)母細胞瘤()
TNFRSF9 Others Mouse 小鼠 4-1BB / TNFRSF9 / CD137 人細胞裂解液 (陽性對照)
SiHa人子宮頸鱗癌細胞 SiHa human uterine cervical squamous cell carcinoma MEM培養(yǎng)基(GIBCO)+10%FBS
人APP-PS1雙基因轉(zhuǎn)染CHO細胞株;7WPS1
小鼠星形膠質(zhì)細胞(MA)(5×105) CaEs-17, 人細胞株 Human
技術(shù)外包服務:
★O位N-乙酰葡萄糖胺OGT抗體費用 分子生物學：質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學：基因合成、引物合成、基因測序、載體構(gòu)建等
★蛋白工程：原核、哺乳動物蛋白表達系統(tǒng)等
★病毒包裝：腺病毒、慢病毒等
★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
★細胞工程：細胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復、克隆形成)、細胞培養(yǎng)、細胞膜制備、穩(wěn)定細胞株構(gòu)建、細胞RNAi技術(shù)等等。
|
|
|
|
